Merck & Co.
AWARDS
NEWS
Many companies appear to be getting their clinical trial news updated ahead of the holidays. Here’s a look.
San Diego-based Janux Therapeutics forged a strategic collaboration with pharma giant Merck potentially worth more than $1 billion to develop next-generation T cell engager immunotherapies for the treatment of cancer.
It’s been a busy day so far for biopharma news and updates. Read on for more.
Moderna’s stock has boomed over the course of 2020, and Merck is cashing in.
Despite the constant need for social distancing, mask-wearing, and the isolation and economic uncertainty that resulted from the outbreak, there is still much to be thankful for when families gather around a virtual table to break bread and carve the turkey this year.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 24, 2020.
JOBS
IN THE PRESS